Search Results 2781-2790 of 18369 for Chronic Lymphocytic Leukemia

1. An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD - Mayo Clinic

   Known chronic obstructive pulmonary disease, persistent asthma, or a history of asthma within 5 years ... Has plasma cell leukemia, Waldenstrom's ...

2. Minnesota Partnership Awards New Grant to Study Myelodysplastic Syndrome - Mayo Clinic News Network

   The latest Partnership grant will fund projects designed to: Identify genes that may be important in both MDS development and progression into leukemia. If ...

3. Vaccine Therapy in Treating Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer Following Surgery and Chemotherapy - Mayo Clinic

   Lymphocytes >= 0.3 x 10^9/L; Total bilirubin =< 2 x upper limit of normal ... Persistent fever (> 24 hours) documented by repeated measurement =< 4 weeks prior to ...

4. Study Evaluating the Prevalence of the KIT D816V Mutation in Peripheral Blood of Patients with Evidence of Systemic Mast Cell Activation (MCA) - Mayo Clinic

   Severe anaphylaxis (Ring and Messmer grading ≥ II) due to Hymenoptera sting, regardless of sBT levels;; Severe ... MC Leukemia (MCL);; MC Sarcoma (MCS).

5. A Study of Atezolizumab Alone or Combined with Immunomodulatory Drug and/or Daratumumab in Multiple Myeloma Patients - Mayo Clinic

   Previous diagnosis of ... Plasma cell leukemia (greater than 2,000 cells ... Uncontrolled, clinically significant pulmonary disease (for example, chronic ...

6. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

   Known history of myelodysplastic syndrome (MDS) or a pre-treatment cytogenetic testing result at risk for a diagnosis of MDS/acute myeloid leukemia (AML) ...

7. Bone Marrow Transplant Program - Experience in treating leukemia and other complex conditions - Mayo Clinic

   Mayo Clinic specialists offer a full range of treatments to people with leukemia, including chemotherapy, targeted therapy, radiation therapy and stem cell ...

8. Clinical trials - Oncology (Medical)

   Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able to ...

9. A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough - Mayo Clinic

   Other severe, acute, or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or ...

10. Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study - Mayo Clinic

    ... chronic medications, transplantation, or chronic infection will not be excluded 3. Female subjects breastfeeding or planning to breastfeed at any time ...